Skip to main content
NCBI home page
Cancer Science logoLink to Cancer Science
. 2005 Aug 19;95(9):745–752. doi: 10.1111/j.1349-7006.2004.tb03256.x

Effect of hepatitis C virus infection on the risk of non‐Hodgkin's lymphoma: A meta‐analysis of epidemiological studies

Keitaro Matsuo 1,3,✉, Aaron Kusano 3, Aravind Sugumar 4, Shigeo Nakamura 2, Kazuo Tajima 1, Nancy E Mueller 3
PMCID: PMC11159764  PMID: 15471561

Abstract

Although a high prevalence of hepatitis C virus (HCV) infection among non‐Hodgkin's lymphoma (NHL) patients had been reported, subsequent epidemiological studies conducted to examine a causal association between HCV and NHL have provided inconsistent results across studies. A strikingly positive association has been reported primarily from Italy and Japan, while no association was found in other regions of the world. To clarify the association between HCV and NHL, we conducted a systematic literature review. Eligible study designs were nested case‐control studies, population‐based case‐control studies, and hospital‐based case‐control studies using non‐cancer subjects as controls. The studies published through January 1991 to August 2003 were searched through Medline. Ultimately, 23 studies with 4049 NHL patients and 1,813,480 controls were identified. Summary statistics were crude odds ratios (ORs) comparing the anti‐HCV se‐ropositive and seronegative subjects. As we identified heterogeneity between studies, summary statistics were calculated based on a random‐effect model. We did not find any evidence of publication bias. The major sources of variation were the use of blood donor controls and year of publication. The summary OR for NHL was 5.70 (95% confidence interval (Cl), 4.09–7.96, P<0.001). The subgroup analysis by phenotype showed a similar trend for B‐cell (5.04, 95% Cl: 3.59–7.06) and T‐NHL (2.51, 95% Cl: 1.39–4.56). In conclusion, we found a strongly positive association between anti‐HCV seropositive test subjects and risk of NHL. Further biological studies examining this association are warranted.

References

  • 1. Matsuo K, Hamajima N, Hirose K, Inoue M, Takezaki T, Kuroishi T, Tajima K. Alcohol, smoking, and dietary status and susceptibility to malignant lym‐phoma in Japan: results of a hospital‐based case‐control study at Aichi Cancer Center. Jpn J Cancer Res 2001; 92: 1011–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Kayali Z, Buckwold VE, Zimmerman B, Schmidt WN. Hepatitis C, cryoglobulinemia, and cirrhosis: a meta‐analysis. Hepatology 2002; 36: 978–85. [DOI] [PubMed] [Google Scholar]
  • 3. Ferri C, La Civita L, Caracciolo F, Zignego AL. Non‐Hodgkin's lymphoma: possible role of hepatitis C virus. JAMA 1994; 272: 355–6. [DOI] [PubMed] [Google Scholar]
  • 4. Yoshida EM, Shariff S, Shenkier T. Hepatitis C and B‐cell non‐Hodgkin's lymphoma: a geographically variable association Am J Med 2000; 108: 350–1. [DOI] [PubMed] [Google Scholar]
  • 5. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, Lombardini F, Greco F, Capochiani E, Mazzoni A. et al. Hepatitis C virus infection in patients with non‐Hodgkin's lymphoma. Br J Haematol 1994; 88: 392–4. [DOI] [PubMed] [Google Scholar]
  • 6. Mazzaro C, Zagonel V, Monfardini S, Tulissi P, Pussini E, Fanni M, Sorio R, Bortolus R, Crovatto M, Santini G, Tiribelli C, Sasso F, Masutti R, Pozzato G. Hepatitis C virus and non‐Hodgkin's lymphomas. Br J Haematol 1996; 94: 544–50. [DOI] [PubMed] [Google Scholar]
  • 7. Musto P, DelľOlio M, Carotenuto M, Mangia A, Andriulli A. Hepatitis C virus infection: a new bridge between hematologists and gastroenterologists Blood 1996; 88: 752–4. [PubMed] [Google Scholar]
  • 8. Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, Russo D, Falasca E, Botta GA, Baccarani M. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4296–301. [PubMed] [Google Scholar]
  • 9. de Rosa G, Gobbo ML, de Renzo A, Notaro R, Garofalo S, Grimaldi M, Apuzzo A, Chiurazzi F, Picardi M, Matarazzo M, Rotoli B. High prevalence of hepatitis C virus infection in patients with B‐cell lymphoproliferative disorders in Italy. Am J Hematol 1997; 55: 77–82. [DOI] [PubMed] [Google Scholar]
  • 10. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M, Qian DG, Velankar M, Nathwani BN, Fong TL. Hepatitis C virus infection in patients with B‐cell non‐Hodgkin lymphoma. Ann Intern Med 1997; 127: 423–8. [DOI] [PubMed] [Google Scholar]
  • 11. Paydas S, Kilic B, Sahin B, Bugdayci R. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey. Br J Cancer 1999; 80: 1303–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Shariff S, Yoshida EM, Gascoyne RD, Le N, Connors JM, Middleton PJ, Shenkier TN. Hepatitis C infection and B‐cell non‐Hodgkin's lymphoma in British Columbia: a cross‐sectional analysis. Ann Oncol 1999; 10: 961–4. [DOI] [PubMed] [Google Scholar]
  • 13. Harakati MS, Abualkhair OA, Al‐Knawy BA. Hepatitis C virus infection in Saudi Arab patients with B‐cell non‐Hodgkin's lymphoma. Saudi Med J 2000; 21: 755–8. [PubMed] [Google Scholar]
  • 14. Mizorogi F, Hiramoto J, Nozato A, Takekuma Y, Nagayama K, Tanaka T, Takagi K. Hepatitis C virus infection in patients with B‐cell non‐Hodgkin's lymphoma. Intern Med 2000; 39: 112–7. [DOI] [PubMed] [Google Scholar]
  • 15. Pioltelli P, Gargantini L, Cassi E, Santoleri L, Bellati G, Magliano EM, Morra E. Hepatitis C virus in non‐Hodgkin's lymphoma. A reappraisal after a prospective case‐control study of 300 patients. Lombart Study Group of HCV‐Lymphoma. Am J Hematol 2000; 64: 95–100. [DOI] [PubMed] [Google Scholar]
  • 16. Zucca E, Roggero E, Maggi‐Solca N, Conconi A, Bertoni F, Reilly I, Castelli D, Pedrinis E, Piffaretti JC, Cavalli F. Prevalence of Helicobacter pylori and hepatitis C virus infections among non‐Hodgkin's lymphoma patients in Southern Switzerland. Haematologica 2000; 85: 147–53. [PubMed] [Google Scholar]
  • 17. Hausfater P, Cacoub P, Sterkers Y, Thibault V, Amoura Z, Nguyen L, Ghillani P, Leblond V, Piette JC. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France. Am J Hematol 2001; 67: 168–71. [DOI] [PubMed] [Google Scholar]
  • 18. Kuniyoshi M, Nakamuta M, Sakai H, Enjoji M, Kinukawa N, Kotoh K, Fukutomi M, Yokota M, Nishi H, Iwamoto H, Uike N, Nishimura J, Inaba S, Maeda Y, Nawata H, Muta K. Prevalence of hepatitis B or C virus infections. in patients with non‐Hodgkin's lymphoma. J Gastroenterol Hepatol 2001; 16: 215–9. [DOI] [PubMed] [Google Scholar]
  • 19. Montella M, Crispo A, de Bellis G, Izzo F, Frigeri F, Ronga D, Spada O, Mettivier V, Tamburini M, Cuomo O. HCV and cancer: a case‐control study in a high‐endemic area. Liver 2001; 21: 335–41. [DOI] [PubMed] [Google Scholar]
  • 20. Montella M, Crispo A, Frigeri F, Ronga D, Tridente V, de Marco M, Fabbrocini G, Spada O, Mettivier V, Tamburini M. HCV and tumors correlated with immune system: a case‐control study in an area of hyperendemic‐ity. Leuk Res 2001; 25: 775–81. [DOI] [PubMed] [Google Scholar]
  • 21. Chindamo MC, Spector N, Segadas JA, Pimenta G, Vanderborght B, Morais JC, Milito C, Moraes Coelho HS. Prevalence of hepatitis C infection in patients with non‐Hodgkin's lymphomas. Oncol Rep 2002; 9: 657–9. [PubMed] [Google Scholar]
  • 22. Imai Y, Ohsawa M, Tanaka H, Tamura S, Sugawara H, Kuyama J, Fukuda K, Yonezawa T, Matsuzawa Y, Matsuzawa Y. High prevalence of HCV infection in patients with B‐cell non‐Hodgkin's lymphoma: comparison with birth cohort‐ and sex‐matched blood donors in a Japanese population. Hepatology 2002; 35: 974–6. [DOI] [PubMed] [Google Scholar]
  • 23. Kaya H, Polat MF, Erdem F, Gundogdu M. Prevalence of hepatitis C virus and hepatitis G virus in patients with non‐Hodgkin's lymphoma. Clin Lab Haematol 2002; 24: 107–10. [DOI] [PubMed] [Google Scholar]
  • 24. Rabkin CS, Tess BH, Christianson RE, Wright WE, Waters DJ, Alter HJ, Van Den Berg BJ. Prospective study of hepatitis C viral infection as a risk factor for subsequent B‐cell neoplasia. Blood 2002; 99: 4240–2. [DOI] [PubMed] [Google Scholar]
  • 25. Aviles A, Valdez L, Halabe J, Neri N, Nellen H, Huerta‐Guzman J, Nambo MJ. No association between lymphoma and hepatitis C virus. Med Oncol 2003; 20: 165–8. [DOI] [PubMed] [Google Scholar]
  • 26. Mele A, Pulsoni A, Bianco E, Musto P, Szklo A, Sanpaolo MG, Iannitto E, de Renzo A, Martino B, Liso V, Andrizzi C, Pusterla S, Dore F, Maresca M, Rapicetta M, Marcucci F, Mandelli F, Franceschi S. Hepatitis C virus and B‐cell non‐Hodgkin lymphomas: an Italian multi‐center case‐control study. Blood 2003. [DOI] [PubMed] [Google Scholar]
  • 27. Iwata H, Matsuo K, Takeuchi K, Kishi Y, Murashige N, Kami M. High incidences of malignant lymphoma in patients infected with hepatitis B or hepatitis C virus. Haematologica 2004; 89: 368–70. [PubMed] [Google Scholar]
  • 28. Vallisa D, Berte R, Rocca A, Civardi G, Giangregorio F, Ferrari B, Sbolli G, Cavanna L. Association between hepatitis C virus and non‐Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course. Am J Med 1999; 106: 556–60. [DOI] [PubMed] [Google Scholar]
  • 29. DerSimonian R, Laird N. Meta‐analysis in clinical trials. Control Clin Trials 1986; 7: 177–88. [DOI] [PubMed] [Google Scholar]
  • 30. Thompson SG, Sharp SJ. Explaining heterogeneity in meta‐analysis: a comparison of methods. Stat Med 1999; 18: 2693–708. [DOI] [PubMed] [Google Scholar]
  • 31. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088–101. [PubMed] [Google Scholar]
  • 32. Global distribution of hepatitis A, B, and C , 2001. World Epidemiological Report, vol. 77. World Health Organization; 2002. p. 45–7.
  • 33. Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, de Martin C, Cristianini G. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology 1994; 20: 1442–9. [DOI] [PubMed] [Google Scholar]
  • 34. Weng WK, Levy S. Hepatitis C virus (HCV) and lymphomagenesis. Leuk Lymphoma 2003; 44: 1113–20. [DOI] [PubMed] [Google Scholar]
  • 35. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998; 4: 1065–7. [DOI] [PubMed] [Google Scholar]
  • 36. Schmidt CM, McKillop IH, Cahill PA, Sitzmann JV. Increased MAPK expression and activity in primary human hepatocellular carcinoma. Biochem Biophys Res Commun 1997; 236: 54–8. [DOI] [PubMed] [Google Scholar]
  • 37. Franzin F, Efremov DG, Pozzato G, Tulissi P, Batista F, Burrone OR. Clonal B‐cell expansions in peripheral blood of HCV‐infected patients. Br J Haematol 1995; 90: 548–52. [DOI] [PubMed] [Google Scholar]
  • 38. Ivanovski M, Silvestri F, Pozzato G, Anand S, Mazzaro C, Burrone OR, Efremov DG. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51pl/VL kv325 immunoglobulin gene combination in hepatitis C virus‐associated immunocytomas. Blood 1998; 91: 2433–42. [PubMed] [Google Scholar]
  • 39. Chan CH, Hadlock KG, Foung SK, Levy S. V(H)l‐69 gene is preferentially used by hepatitis C virus‐associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood 2001; 97: 1023–6. [DOI] [PubMed] [Google Scholar]
  • 40. Quinn ER, Chan CH, Hadlock KG, Foung SK, Flint M, Levy S. The B‐cell receptor of a hepatitis C virus (HCV)‐associated non‐Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 2001; 98: 3745–9. [DOI] [PubMed] [Google Scholar]
  • 41. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S. Binding of hepatitis C virus to CD81. Science 1998; 282: 938–41. [DOI] [PubMed] [Google Scholar]
  • 42. Carter RH, Fearon DT. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992; 256: 105–7. [DOI] [PubMed] [Google Scholar]
  • 43. Wack A, Soldaini E, Tseng C, Nuti S, Klimpel G, Abrignani S. Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co‐stimulatory signal for human T cells. Eur J Immunol 2001; 31: 166–75. [DOI] [PubMed] [Google Scholar]
  • 44. Soldaini E, Wack A, D'Oro U, Nuti S, Ulivieri C, Baldari CT, Abrignani S. T cell costimulation by the hepatitis C virus envelope protein E2 binding to CD81 is mediated by Lck. Eur J Immunol 2003; 33: 455–64. [DOI] [PubMed] [Google Scholar]
  • 45. Iannitto E, Barbera V, Gambino R, Ammatuna E, Montalto G, Di Stefano R. Higher frequency of HCV in patients with non‐Hodgkin lymphoma: is it enough to suggest an association with B‐cell NHL Hepatology 2003; 37: 481–2 (author reply 482). [DOI] [PubMed] [Google Scholar]
  • 46. Ohsawa M, Shingu N, Miwa H, Yoshihara H, Kubo M, Tsukuma H, Teshima H, Hashimoto M, Aozasa K. Risk of non‐Hodgkin's lymphoma in patients with hepatitis C virus infection. Int J Cancer 1999; 80: 237–9. [DOI] [PubMed] [Google Scholar]
  • 47. No author listed. Age‐standardized and cumulative incidence rates (three‐digit rubrics). In: Parkin DM, Whelan SL, Ferlay J, Teppo L, Thoma DB. editors Cancer in five continents. Vol VIII. Lyon : IARC Scientific Pub; 2002. p. 675–7. [Google Scholar]
  • 48. Hepatitis C: global prevalence. World Epidemiological Report. vol. 72. World Health Orgnaization; 1997. p. 341–8.
  • 49. Takezaki T, Tajima K, Ito M, Ito S, Kinoshita K, Tachibana K, Matsushita Y. Short‐term breast‐feeding may reduce the risk of vertical transmission of HTLV‐I. The Tsushima ATL Study Group. Leukemia 1997; 11 Suppl 3: 60–2. [PubMed] [Google Scholar]
  • 50. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG. Regression of primary low‐grade B‐cell gastric lymphoma of mucosa‐associated lymphoid tissue type after eradication of Helicobacter pylori . Lancet 1993; 342: 575–7. [DOI] [PubMed] [Google Scholar]
  • 51. Hermine O, Lefrere F, Bronowicki JP, Mariette X, Jondeau K, Eclache‐Saudreau V, Delmas B, Valensi F, Cacoub P, Brechot C, Varet B, Troussard X. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 89–94. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Science are provided here courtesy of Wiley

RESOURCES